The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Vaxcyte at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

Vaxcyte takes part in 2 sessions at World Vaccine Congress 2027 in Washington. Its sessions cover vaccine partnering and pneumococcal disease. One presents pivotal data for a 31-component pneumococcal vaccine.

OrganizationWorld Vaccine Congress 2027 Attendance
Vaxcyte
San Carlos, CA
vaxcyte.com
Biotech
Develops broad-spectrum conjugate vaccines, led by a 31-valent pneumococcal vaccine candidate.
Panel
Wed Mar 10
09:10
Panel: Pharma Ready: What It Really Takes to Seal the Deal
What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation.
with Omniose, Eli Lilly, Sanofi
Talk
Wed Mar 10
14:40
VAX-31 - pivotal data for a 31-component pneumococcal vaccine (Opus 1, 2, & 3 Trials)
Influenza & Respiratory Diseases Track

Explore the full World Vaccine Congress 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Vaxcyte

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction